Notice: Trying to get property 'post_parent' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/header.php on line 66

Notice: Trying to get property 'ID' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/header.php on line 71

Notice: Trying to get property 'post_name' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/header.php on line 75

Notice: Trying to get property 'post_parent' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/components/layout-header.php on line 44

Notice: Trying to get property 'ID' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/components/layout-header.php on line 49

Notice: Trying to get property 'post_name' of non-object in /home/oxfordcapital/webapps/oxford-capital-live/wp-content/themes/oxfordcapital/components/layout-header.php on line 53
Change Visitor Type Sign up to our newsletter

NEWS & VIEWS

Oxford Capital and our portfolio companies

The future of venture capital in Europe?

By Oxford Capital November 21, 2013
This year’s Slush conference, held in Helsinki, brought some of Europe’s most promising start-ups together with technology giants including Spotify, Alibaba and Rovio. Oxford Capital attended the event, which highlighted the opportunities and challenges facing entrepreneurs and growth investors across Europe. Walking around Helsinki’s Kaapelitehdas building, it was hard not to be impressed by the…
Read More

Oxford Capital Exits Sirigen In Sale To Becton Dickinson

By Oxford Capital August 28, 2013
Venture capital backed High Sensitivity Fluorescence Business, Sirigen Group Limited, has been acquired by BD (Becton, Dickinson and Company), a leading global medical technology company for an undisclosed sum. Founded in 2004, Sirigen uses Nobel-prize winning science to produce light harvesting polymers which have a wide range of applications in research, medical diagnostics and life…
Read More

The growth potential for Cloud Computing

By Oxford Capital May 27, 2013
Following our investment in Abiquo, a Cloud management software developer, this month we examine the continued growth and investment potential of the Cloud industry. The Cloud Computing market includes many innovative, fast-growing businesses, each of which has a ready-made list of potential acquirers among the sector’s big Infrastructure providers. The global market increased from $20…
Read More

Oxford Capital Leads Abiquo Funding Round

By Oxford Capital April 11, 2013
US$5 million growth capital investment positions enterprise cloud management software leader for accelerated commercial growth. Specialist growth capital investor Oxford Capital has led a US$5 million funding round into Abiquo an award-winning enterprise cloud management software provider. Oxford Capital joins existing investors Balderton Capital and Nauta Capital as major backers. The investment will enable Abiquo…
Read More

Oxford Capital Named Best EIS Fund Manager

By Oxford Capital February 14, 2013
Top EISA award completes the hat trick for Oxford Capital. Specialist investment manager Oxford Capital has been named the best eis fund manager, having won the EIS Sponsor/Fund Manager of the Year award at the EIS Association (EISA) Awards held at the House of Lords in London on 13 February 2013. Oxford Capital is the…
Read More

AWARDS

20221216 Award logos layout